Learn about our healthcare areas

Explore medicine and therapy products
Explore MedTech products

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      1. Home/
      2. Media Center/
      3. Press releases /
      4. Innovative Medicine

      Innovative Medicine

      Innovative Medicine
      May 23, 2012

      FDA Advisory Committee Recommends Against Approval of Oral Anticoagulant XARELTO® to Reduce the Risk of Secondary Cardiovascular Events in Patients with Acute Coronary Syndrome

      Learn more
      Innovative Medicine
      May 23, 2012

      Janssen Healthcare Innovation Announces Discharge Decision Support System (D2S2) Winner of the Janssen Connected Care Challenge

      $100,000 award to advance commercialization of D2S2 transition care solution designed to deliver better patient care and reduce hospital readmissions
      Learn more
      Innovative Medicine
      May 21, 2012

      New Phase 3 Study Results Show Anti-TNF SIMPONI® Induced Clinical Response in Adults with Moderately To Severely Active Ulcerative Colitis

      First Presentation of Phase 3 Data Shows Significant Improvements in Clinical Remission, Mucosal Healing and Quality of Life Measures after SIMPONI Induction Treatment
      Learn more
      Innovative Medicine
      May 18, 2012

      ZYTIGA® (abiraterone acetate) Data to be Presented at 2012 American Society of Clinical Oncology (ASCO) Annual Meeting

      Note: This release corresponds to ASCO abstracts LBA 4518, 4521, 4556 and 4558
      Learn more
      Innovative Medicine
      May 17, 2012

      Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)

      Study results presented at the 31st Annual Scientific Meeting of the American Pain Society
      Learn more
      Innovative Medicine
      May 9, 2012

      Janssen Research & Development Submits Supplemental New Drug Application To U.S. FDA For XARELTO® (rivaroxaban) To Reduce The Risk Of Stent Thrombosis In Patients With Acute Coronary Syndrome

      Learn more
      Innovative Medicine
      May 2, 2012

      Janssen Research & Development Submits XARELTO® (rivaroxaban) to U.S. FDA for the Treatment and Prevention of Recurrent Venous Thromboembolism

      Learn more
      Innovative Medicine
      April 25, 2012

      Janssen Neuroscientists And Colleagues Discuss Role Of Mitochondrial Dysfunction In Neuropsychiatric Disorders In Nature Reviews Article

      Article Points to Major Role Mitochondrial Function May Play in Development of Depression and Bipolar Disorder; Calls for New Treatment Approaches, More Efficient Drug-Development
      Learn more
      Innovative Medicine
      April 12, 2012

      Janssen Therapeutics Establishes Point Scholarship for LGBT Students

      Learn more
      Load More